about
Gene-wide characterization of common quantitative trait loci for ABCB1 mRNA expression in normal liver tissues in the Chinese populationHistone methyltransferase MLL1 regulates MDR1 transcription and chemoresistanceRoles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.Colorectal cancers and chlorinated waterThe role of drug transporters in the kidney: lessons from tenofovirABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in micePossible association of ABCB1:c.3435T>C polymorphism with high-density-lipoprotein-cholesterol response to statin treatment--a pilot study.Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.ABC of oral bioavailability: transporters as gatekeepers in the gut.ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysisColorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms.ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysisPharmacogenetics-based new therapeutic concepts.The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance.Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.Phorbol 12-myristate 13-acetate inhibits P-glycoprotein-mediated efflux of digoxin in MDCKII-MDR1 and Caco-2 cell monolayer models.ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding.Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments.Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxibIn vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancerAdverse effects of concentrated green tea extracts.Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin.Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells.Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells.Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd.Effects of continuous exposure to digoxin on MDR1 function and expression in Caco-2 cells.Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test.P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth.Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/adr cells.Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany.Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study.Methadone as a "Tumor Theralgesic" against Cancer.Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat.Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin.
P2860
Q21560761-6E431DA9-10C7-4F81-8037-68F14EAE8943Q24300652-DF596BDF-C74E-4EB8-87EB-1C55B30F00D1Q25255438-E93EF34D-E567-4F4E-9695-549F9C9E23AAQ26751646-96A85BB0-7118-45F5-9342-3351B932F957Q26866489-4613DE94-05B6-46BC-8621-2BB4F44E6032Q34084892-88B023FF-0389-4E40-9B97-7A458145C7EEQ35025106-ED629782-C85E-4EE5-A567-705E2EF86510Q35099950-D0DAC6FF-F7A9-44F3-B6EC-E09672999183Q35164664-19C9D263-1F1D-445D-A965-5A900E3B5CBFQ35591517-B3015B7A-F1E0-4C69-B76D-0A7BF30C495CQ35593505-9DE3BC53-C3F4-4671-B6E4-ADB7B90D734DQ35596829-AD66DC01-A56B-4A43-AF4B-005ED4FACA3CQ35799847-34B01D4A-997C-47D5-98F7-D91189EB7952Q35956177-98D2A64D-73A7-4B5D-B102-D13419A1ECFCQ35956193-55B68310-E565-480D-AE1F-EE162CAEAEB4Q36163801-8813F227-7602-4A91-AB7C-222C6BC94F9DQ36288839-75CA0A17-84AE-4229-A0A1-3E8F262FDE02Q36295334-3480FB44-69A4-4264-81DD-FA4452EAE5D1Q36592129-08097243-793B-4345-884F-7B94FABEDD2EQ36609763-DDDB1640-1356-4EB4-97A9-86F97B789CB7Q36662888-2EC1CA5C-F0B2-4EE2-8B81-A638D7FEAAFAQ36691249-02D3B772-CD18-4251-B380-04D2E7C1AA13Q37175779-BEC95842-EC8D-4ECC-8679-EDAFE3BB0A5DQ37383842-8277D9FA-2ED5-4F6C-9E3D-2C4DC182FA1DQ37871561-C100182E-D021-4B9F-94CA-9752A4F4CDAAQ37907381-2D21B8C2-8703-4AE8-9908-A7964755F743Q37964754-B981BDC9-CF38-448F-B583-C6DC6498CFCCQ38024092-A9BF5979-2802-4C7C-A25C-B655862A7E88Q40277195-CE9CB0AA-20F8-4D5A-9C23-655BB3E0E761Q41774697-D0244147-5B12-4202-92D4-ABD2AAFE4569Q44285094-1E5DB4AE-69EB-4055-94A5-816C71F16727Q44494626-2C3DC3F7-95BC-4F72-9FB7-AF4EE1A5D8F8Q44543753-E69727FF-1100-47E2-8DDB-46EDDB948965Q45018796-BEBBA2B3-8AF7-4AFF-A36D-12ECE3C9F99BQ45220374-2F204E61-9382-4C50-8DBC-AE3B3E87EFA3Q46846896-CDD68A00-27E4-4F11-8225-0F4ECAD3D3E9Q46853630-3B138D94-88E9-41C9-A9DB-88C91EE97626Q47150971-F5082E36-15B9-459C-AB10-492A8F0D4F61Q47939695-ED81C2DE-1777-4B8A-BB49-2DB00F6B14B4Q48662628-9E36D0AE-58D3-4488-A5F0-928B050B03D5
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Role of P-glycoprotein in drug disposition.
@ast
Role of P-glycoprotein in drug disposition.
@en
type
label
Role of P-glycoprotein in drug disposition.
@ast
Role of P-glycoprotein in drug disposition.
@en
prefLabel
Role of P-glycoprotein in drug disposition.
@ast
Role of P-glycoprotein in drug disposition.
@en
P1476
Role of P-glycoprotein in drug disposition.
@en
P2093
Tanigawara Y
P304
P356
10.1097/00007691-200002000-00029
P577
2000-02-01T00:00:00Z